Cargando…
1386. Reduction in Expected Survival Associated with Nontuberculous Mycobacterial Pulmonary Infection
BACKGROUND: Nontuberculous mycobacteria (NTM) are emerging agents of pulmonary disease, estimated to affect >80,000 people in the United States. While the spectrum of pulmonary NTM severity is broad, some published series report 5-year mortality of up to 40%. METHODS: We conducted a retrospective...
Autores principales: | Mourad, Ahmad, Baker, Arthur W, Stout, Jason E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809282/ http://dx.doi.org/10.1093/ofid/ofz360.1250 |
Ejemplares similares
-
877. Use of Statistical Process Control Charts for Early Detection of Healthcare Facility-Associated Nontuberculous Mycobacterial Outbreaks
por: Baker, Arthur W, et al.
Publicado: (2020) -
Extrapulmonary Nontuberculous Mycobacterial Infections in Southern Arizona
por: Florita, Catalin, et al.
Publicado: (2017) -
1389. Nontuberculous Mycobacterial Infections of the Upper Extremity
por: Polveroni, Thomas M, et al.
Publicado: (2021) -
1359. Clinical Experience and Challenges Utilizing Clofazimine in the Treatment of Nontuberculous Mycobacterial Pulmonary Infections
por: Mercurio, Amanda, et al.
Publicado: (2019) -
1386. Chagas Disease in Chile: an Old and Forgotten
por: Novoa, Catalina, et al.
Publicado: (2023)